News 1030
  1. Published: 24 May 2023

    May 24: World Schizophrenia Day

    Today, the report of the project “Developing trust and effective care for people with schizophrenia” by Gamian Europe, in collaboration with the European Psychiatric Association and with the support of Angelini Pharma, has been released.

  2. Published: 18 Mar 2021

    Stay Aware!

    In 2020, billions of people faced a global pandemic for the first time in their lives, without having any experience or preparation for it. In this year everyone had to find new emotional, mental and physical resources. Angelini Pharma also wanted to do its part.

  3. Published: 29 Jan 2021

    Positive CHMP opinion for Cenobamate

    Cenobamate has received a positive CHMP opinion for the adjunctive treatment of focal onset seizures with or without secondary generalization in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic products.

  4. Published: 2 Dec 2020

    Ovid Therapeutics

    Ovid Therapeutics yesterday announced the topline results from the Company’s Phase III NEPTUNE clinical trial of OV101 (gaboxadol) for the treatment of Angelman syndrome.